MicafunginImmuneSafety Rating 8/10

Primary research areaInvasive candidiasis

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range100-150 mg once daily IV
AdministrationIntravenous
Safety8/10 · FDA-approved (Mycamine)
NCAA D1Permitted

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Micafungin

Mechanism of action

Echinocandin antifungal; non-competitive inhibitor of beta-1,3-glucan synthase

Safety profile

Hepatotoxicity risk, nausea, rash, elevated liver tests · Well-established echinocandin; hepatotoxicity monitoring; generally well-tolerated

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Micafungin

Failed to fetch